BRD4 and breast carcinoma: 9 f (FL-411), a novel small-molecule that potently inhibits Brd4-BD1, induces AMPK-modulated autophagic cell death of breast cancer both in vitro and in vivo [14], suggesting that Brd4 inhibition-mediated autophagy also displays a therapeutic potential on breast cancer.